Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Lyka Labs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1986 on BSE, Feb 1995 on NSE
Last close ₹76.60up ₹0.35 (0.46%)BSE ₹77.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹76.25.
30 Oct: open ₹77.77, high ₹77.77, low ₹76.60
52-week range of traded prices to 30 Oct 2026
₹44.10Low, 30 Mar 2026₹98.25High, 31 Oct 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹277 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,475
Lyka Labs has 1,492 announcements on record, routine notices left out; 3 in the 30 days to 1 Nov 2026, the latest on 30 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Lyka Labs quarterly results
Oct30Fri
The board met on 30 Oct 2026 to consider financial results
Notice filed 14 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Lyka Labs annual reports, presentations and earnings calls
The company's own documents, latest first.Lyka Labs financials, year by year
Annual reports30
- Annual report, year to Mar 202617 Jul 2026
- Annual report, year to Mar 20258 Jul 2025
- Annual report, year to Mar 202416 Jul 2024
- Annual report, year to Mar 202310 Jul 2023
- Annual report, year to Mar 202211 Jul 2022
25 earlier reports
- Annual report, year to Mar 20218 Jul 2021
- Annual report, year to Mar 20203 Sep 2020
- Annual report, year to Mar 201928 Aug 2019, a zip file
- Annual report, year to Mar 20186 Oct 2018, a zip file
- Annual report, year to Mar 201716 Oct 2017, a zip file
- Annual report, year to Mar 20166 Oct 2016, a zip file
- Annual report, year to Mar 20159 Dec 2015, a zip file
- Annual report, year to Jun 20159 Dec 2015
- Annual report, year to Mar 201412 Dec 2014, a zip file
- Annual report, year to Jun 20146 Dec 2014
- Annual report, year to Mar 201326 Sep 2013, a zip file
- Annual report, year to Mar 201218 Sep 2012, a zip file
- Annual report, year to Mar 201013 Apr 2011, a zip file
- Annual report, year to Sep 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Lyka Labs merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings37
- As per the letter attached9 Apr 2026
- Update on the Scheme of Merger- Approved by NCLT Bench17 Mar 2026
- As per the letter attached20 Feb 2026
- As per the letter attached2 Feb 2026
- As per the letter attached22 Dec 2025
32 earlier filings
- As per letter atatched5 Dec 2025
- As per letter attached8 Nov 2025
- As per the letter attached11 Oct 2025
- As per letter attached18 Sep 2025
- As per letter attached8 Aug 2025
- As per letter attached11 Jul 2025
- As per letter attached13 Jun 2025
- As per letter attached22 May 2025
- As per letter attached1 Apr 2025
- As per attached letter24 Jan 2025
- As per attachment26 Oct 2024
- LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/10/2024 ,inter alia, to consider and approve As per attachment4 Oct 2024
- Amalgamation/Merger23 Aug 2024
- Company updates on Scheme of Amalgamation, as enclosed.23 Aug 2024
- Amalgamation/Merger23 Jul 2024
- Company submitted the updation on the NCLT hearing of the Scheme of Amalgamation, as mentioned therein.23 Jul 2024
- Amalgamation/Merger19 Jul 2024
- Company enclosed updates about the Scheme of Amalgamation, as mentioned therein.19 Jul 2024
- Updates on the Scheme of Amalgamation for its next hearing is enclosed herewith.7 Jun 2024
- Update on the Scheme of Amalgamation w.r.t its next hearing is enclosed herewith.18 Apr 2024
- Company in receipt of the Order from the Hon'ble NCLT through Updation on its website on 11th March 2024, The Company will be ensure the necessary instructions as per the Order before ....12 Mar 2024
- On approvals of the all Stakeholders, The Joint Petition by Lyka Labs Limited and Lyka Exports Limited has been e-filed on 28th February 2024 with the NCLT under Sections 230 -232 and ....29 Feb 2024
- This is with reference to our previous intimation dated 25th November 2023, the revised order has been uploaded on the Hon'ble NCLT website. The same has been also uploaded on the website ....9 Jan 2024
- Update on the scheme of amalgmation25 Nov 2023
- Pursuant to the receipt of Observation Letters from the Stock Exchanges, a joint application by Lyka Exports Limited and the Company for the Scheme of Amalgamation has been filed on 12th ....13 Oct 2023
- Observation Letter regarding scheme of Amalgmation of Lyka Exports Limited with Lyka Labs Limited.3 Aug 2023
- With respect to above we wish to inform you that Lyka Exports Limited a subsidiary, is amalgamating with its holding Company w.e.f. 1st April, 2022 (Appointed Date). We provide following documents for your processing our application for amalgamation viz:1. Scheme of Amalgamation.2. Board Resolutions passed by Board of Directors of Lyka Exports Limited and Lyka Labs Limited approving scheme of amalgamation of Lyka Exports Limited with Lyka Labs Limited. 3. Valuation Report provided by Bhavesh M. Rathod- Registered Valuer.4. Fairness Opinion regarding Valuation of Shares and Exchange Ratio provided by Kunvarji Finstock Private Limited- SEBI Registered Category I Merchant Banker. 5. Audit Committee Report.6. Auditors Certificate under section 133 of the Companies Act, 2013 provided by M/s. D. Kothary & Co, Chartered Accountants, for accounting treatment to be given in the proposed amalgamation separately for Lyka Labs Limited and Lyka Exports Limited.Limited has informed the Exchange about Amalgamation/Merger16 Aug 2022
- With respect to above we wish to inform you that Lyka Exports Limited a subsidiary, is amalgamating with its holding Company w.e.f. 1st April, 2022 (Appointed Date). We provide following ....16 Aug 2022
- LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2022 ,inter alia, to consider and approve 1. Standalone and Consolidated Un-Audited ....1 Aug 2022
- In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered Merger of Lyka Exports ....29 Oct 2021
- We are pleased to inform you that NCLT, Ahmedabad has passed an Order dated 12th October, 2020 approving merger of Lyka Healthcare Limited with Lyka Labs Limited which was received today. ....20 Oct 2020
- Board of Directors of the company at their meeting held on May 29,2017, have approved the Scheme of Amalgamation of Lyka Healthcare Limited (Transferor Company) being the wholly owned subsidiary with Lyka Labs Limited (Transferee Company) w.e.f 1st April, 2017 as per the terms and conditions mentioned in the Scheme of Amalgamation (the Scheme) subject to requisite approvals.30 May 2017, a zip file
Lyka Labs share news and announcements
Newest first. Page 1 of 30.
Oct 2026
30 Oct · Results
14 Oct · Board meeting
Aug 2026
11 Aug · Meeting
11 Aug
11 Aug · Results
10 Aug · Meeting
10 Aug · Meeting
10 Aug
10 Aug · Results
10 Aug · Results
10 Aug · Results
10 Aug · Board meeting
Jul 2026
24 Jul · Board meeting
17 Jul
17 Jul
17 Jul · Meeting
17 Jul · Letter Sent To Shareholders
17 Jul · Meeting
17 Jul · Meeting
Jun 2026
30 Jun
30 Jun · Disclosure
26 Jun · Disclosure
26 Jun
17 Jun
17 Jun · Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - GST
12 Jun
12 Jun · Announcement under Regulation 30 (LODR)-Allotment
11 Jun
11 Jun · Legal
11 Jun · Legal
Significant movement in price has been observed in Lyka Labs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.11 Jun · Legal
Clarification sought from Lyka Labs Ltd4 Jun · Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 - NCLT, Appellate Tribunal, New Delhi Bench
4 Jun
May 2026
25 May · Results
25 May · Board meeting
25 May · Results
12 May · Board meeting
Apr 2026
30 Apr · Rating
9 Apr
9 Apr · Business
9 Apr · Legal
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 10 Aug 2026Resultsup 1.99%+1.9 pts vs Nifty 500market median −0.7% · five sessions −0.1% (+0.4 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 26 May 2026Resultsdown 3.06%−2.9 pts vs Nifty 500market median −0.7% · five sessions −6.1% (−4.4 pts vs Nifty 500) · volume 6.3× usual · The announcement
- 4 May 2026Credit ratingdown 3.38%−4.0 pts vs Nifty 500market median 0.0% · five sessions +9.5% (+7.6 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 9 Mar 2026Board or managers changeddown 5.17%−3.3 pts vs Nifty 500market median 0.0% · five sessions −13.1% (−8.3 pts vs Nifty 500) · volume 1.8× usual · delivery +9.7 pts against usual · The announcement
- 30 Jan 2026Resultsdown 2.21%−2.0 pts vs Nifty 500market median −0.7% · five sessions −1.7% (−3.4 pts vs Nifty 500) · volume 0.7× usual · delivery −11.2 pts against usual · The announcement
- 12 Nov 2025Resultsdown 0.83%−1.5 pts vs Nifty 500market median −0.7% · five sessions −10.6% (−11.2 pts vs Nifty 500) · volume 2.4× usual · delivery −22.4 pts against usual · The announcement
- 2 Sep 2025Board or managers changedup 1.27%+1.2 pts vs Nifty 500market median 0.0% · five sessions −0.8% (−1.5 pts vs Nifty 500) · volume 0.5× usual · delivery −10.9 pts against usual · The announcement
- 1 Sep 2025Board or managers changedup 0.16%−1.0 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−1.7 pts vs Nifty 500) · volume 0.7× usual · delivery +6.7 pts against usual · The announcement
- 1 Aug 2025Resultsdown 4.76%−3.7 pts vs Nifty 500market median −0.7% · five sessions −9.3% (−8.4 pts vs Nifty 500) · volume 5.1× usual · delivery −16.7 pts against usual · The announcement
- 1 Aug 2025Board or managers changeddown 4.76%−3.7 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−8.4 pts vs Nifty 500) · volume 5.1× usual · delivery −16.7 pts against usual · The announcement
20 earlier announcements
- 7 Jul 2025Board or managers changeddown 1.70%−1.7 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−2.0 pts vs Nifty 500) · volume 0.7× usual · delivery +3.1 pts against usual · The announcement
- 27 May 2025Resultsdown 1.94%−1.5 pts vs Nifty 500market median −0.7% · five sessions +1.8% (+2.1 pts vs Nifty 500) · volume 0.9× usual · delivery +9.8 pts against usual · The announcement
- 27 May 2025Board or managers changeddown 1.94%−1.5 pts vs Nifty 500market median 0.0% · five sessions +1.8% (+2.1 pts vs Nifty 500) · volume 0.9× usual · delivery +9.8 pts against usual · The announcement
- 12 May 2025Board or managers changedup 1.54%−2.3 pts vs Nifty 500market median 0.0% · five sessions +9.7% (+4.2 pts vs Nifty 500) · volume 0.8× usual · delivery +11.9 pts against usual · The announcement
- 27 Feb 2025Credit ratingdown 0.26%+0.2 pts vs Nifty 500market median 0.0% · five sessions −2.3% (−1.5 pts vs Nifty 500) · volume 1.7× usual · delivery +22.9 pts against usual · The announcement
- 4 Feb 2025Resultsup 3.36%+1.8 pts vs Nifty 500market median −0.7% · five sessions −4.8% (−4.7 pts vs Nifty 500) · volume 1.4× usual · delivery −5.9 pts against usual · The announcement
- 13 Nov 2024Board or managers changeddown 5.88%−4.0 pts vs Nifty 500market median 0.0% · five sessions −3.6% (−1.3 pts vs Nifty 500) · volume 1.0× usual · delivery +5.1 pts against usual · The announcement
- 12 Nov 2024Resultsup 1.82%+3.0 pts vs Nifty 500market median −0.7% · five sessions −0.6% (+2.0 pts vs Nifty 500) · volume 5.0× usual · delivery −30.6 pts against usual · The announcement
- 12 Nov 2024Board or managers changedup 1.82%+3.0 pts vs Nifty 500market median 0.0% · five sessions −0.6% (+2.0 pts vs Nifty 500) · volume 5.0× usual · delivery −30.6 pts against usual · The announcement
- 9 Aug 2024Resultsup 10.43%+9.5 pts vs Nifty 500market median −0.7% · five sessions +4.6% (+3.1 pts vs Nifty 500) · volume 11.0× usual · delivery −22.8 pts against usual · The announcement
- 9 Aug 2024Board or managers changedup 10.43%+9.5 pts vs Nifty 500market median 0.0% · five sessions +4.6% (+3.1 pts vs Nifty 500) · volume 11.0× usual · delivery −22.8 pts against usual · The announcement
- 8 Feb 2024Resultsup 5.83%+6.4 pts vs Nifty 500market median −0.7% · five sessions −4.3% (−3.3 pts vs Nifty 500) · volume 13.3× usual · The announcement
- 20 Dec 2023Credit ratingdown 2.49%−0.5 pts vs Nifty 500market median 0.0% · five sessions +0.8% (+0.2 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 2 Nov 2023Resultsup 1.06%+0.1 pts vs Nifty 500market median −0.7% · five sessions +0.5% (−2.6 pts vs Nifty 500) · volume 1.1× usual · delivery −11.1 pts against usual · The announcement
- 23 May 2023Resultsdown 2.83%−3.1 pts vs Nifty 500market median −0.7% · five sessions −3.5% (−5.2 pts vs Nifty 500) · volume 2.4× usual · delivery −23.5 pts against usual · The announcement
- 7 Feb 2023Resultsdown 1.78%−1.6 pts vs Nifty 500market median −0.7% · five sessions −2.8% (−2.6 pts vs Nifty 500) · volume 0.4× usual · delivery −25.5 pts against usual · The announcement
- 10 Aug 2022Board or managers changeddown 9.11%−9.1 pts vs Nifty 500market median 0.0% · five sessions −10.1% (−12.6 pts vs Nifty 500) · volume 1.6× usual · delivery +10.8 pts against usual · The announcement
- 2 Aug 2022Board or managers changeddown 3.46%−3.7 pts vs Nifty 500market median 0.0% · five sessions −6.9% (−7.9 pts vs Nifty 500) · volume 0.8× usual · delivery +4.8 pts against usual · The announcement
- 21 Jan 2022Resultsdown 4.99%−3.8 pts vs Nifty 500market median −0.7% · five sessions −22.6% (−18.4 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 5 Aug 2021Resultsup 4.95%+4.9 pts vs Nifty 500market median −0.7% · five sessions +4.4% (+5.1 pts vs Nifty 500) · volume 6.0× usual · delivery −21.8 pts against usual · The announcement
Lyka Labs results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Other expenses | Year to date to Dec 2025 | Standalone | 27.54 | 27.54 | 0.0% | 29 Jan 2026 | 29 Jan 2026 |
| Total expenses | Year to date to Dec 2025 | Standalone | 99.36 | 99.36 | 0.0% | 29 Jan 2026 | 29 Jan 2026 |
| Profit before tax | Year to date to Dec 2025 | Standalone | −3.35 | −3.35 | 0.0% | 29 Jan 2026 | 29 Jan 2026 |
| Net profit | Year to date to Dec 2025 | Standalone | −2.53 | −2.53 | 0.0% | 29 Jan 2026 | 29 Jan 2026 |
| Profit before one-off items and tax | Year to date to Dec 2025 | Standalone | −3.35 | −3.35 | 0.0% | 29 Jan 2026 | 29 Jan 2026 |
| Net profit from continuing businesses | Year to date to Dec 2025 | Standalone | −2.53 | −2.53 | 0.0% | 29 Jan 2026 | 29 Jan 2026 |
| Total comprehensive income | Year to date to Dec 2025 | Standalone | −2.55 | −2.55 | 0.0% | 29 Jan 2026 | 29 Jan 2026 |